Professor Banning is the author of several books on international cardiology and has over 300 scientific papers attributed to his name

He’s also been Assistant Editor of The Heart Journal, Co-Editor of Cardiovascular Medicine for the journal Medicine and is a reviewer for a number of international cardiology journals (including The Lancet, Circulation and Heart).

He also provides peer review for grant awarding bodies, including: British Heart Foundation, Heart Research UK, Wellcome Trust, NHS Technology group and NIHR.

Click on the plus icon to reveal the full list of papers and publications within each section.

1) Banning AP, Pearson JF, Hall RJC.

The role of balloon aortic valvotomy in pregnant patients with severe aortic stenosis.

Br Heart J 1993; 70:544-545

2) Banning AP, Masani ND, Ikram S, Fraser AG, Hall RJC.

Transoesophageal echocardiography as the sole diagnostic investigation in patients with suspected thoracic aortic dissection.

Br Heart J 1994; 72: 461-65.

3) Maire R, Ikram S, Odemuyiwa O, Groves PH, Lo SV, Banning AP, Hall RJC.

Abnormalities of left ventricular flow following mitral valve replacement:

a colour flow Doppler study.

Eur Heart J 1994; 15:293-302

4) Avery PA, Banning AP, Lawson TM, McGurk L, Buchalter MB.

Physiological pacing improves symptoms and increases exercise capacity in the elderly patient.

Int J Cardiol 1994; 46: 129-133.

5) Banning AP, Lewis NP, Northridge DB, Elborn JS, Henderson AH.

Perfusion/ventilation mismatch during exercise in chronic heart failure: an investigation of circulatory determinants.

Br Heart J 1995; 74: 27-33.

6) Banning AP, Lewis NP, Elborn JS, Hall RJC.

Exercise ventilation after balloon dilatation of the mitral valve.

Br Heart J 1995; 74: 386-389

(letter – in response)

Heart 1996; 75:322

7) Banning AP, Jones R, Ikram S, Lewis NP, Hall RJC.

Can an echocardiographic score predict who will benefit clinically from balloon dilatation of the mitral valve.

Int J Cardiol 1995; 51: 285-292

8) Groves PH, Banning AP, Cheadle HA, Penny WJ, Lewis MJ.

The influence of exogenous nitric oxide on smooth muscle cell proliferation

and intimal thickening in a porcine model of balloon angioplasty.

Cardiovascular Research 1995; 30: 87-96.

9) Groves PH, Banning AP, Lewis MJ, Cheadle HA, Penny WJ, Newby AC

Smooth muscle cell proliferation and intimal thickening in a porcine model of balloon angioplasty.

Atherosclerosis 1995; 117: 83-96.

10) Westaby S, Amarasena N, Long V, Prothero A, Amarasena C, Banning AP, Pillai R, Ormerod O.

Time related changes after aortic valve replacement with the Freestyle stentless xenograft.

Ann of Thoracic Surg 1995 ; 60: 1633-9

11) Banning AP, Ramsey MW, Jones EA, EvansWD, Carolan-Rees G,

Jones CH, Henderson AH.

Flosequinan in chronic heart failure: How is exercise capacity improved?.

European J Clin Pharm 1996; 51: 133-138.

12) Banning AP, Musumeci F, Penny WJ, Tovey JA.

Reference intervals for cardiac troponin T, creatinine kinase and creatinine kinase-MB isoenzyme following coronary bypass graft surgery.

Ann Clin Biochem 1996; 33: 561-2

13) Masani ND, Banning AP, Jones RA, Ruttley MST, Fraser AG.

Follow up of chronic aortic dissection: a comparison of transoesophageal echocardiography and magnetic resonance imaging.

Am Heart J 1996; 131: 1156-63

14) Lewis NP, Banning AP, Cooper JP, Sundar AS, Facey PE, Evans WD, Henderson AH.

Impaired matching of perfusion and ventilation in heart failure detected by 133Xenon.

Basic Res Cardiol 1996; 91: Suppl 1: 45-49

15) Southgate KM, Fisher M, Banning AP, Thurston VJ, Fabunmi R, Baker AH, Groves PH, Davies M, Newby AC

Upregulation of basement membrane degrading metalloproteinase secretion after balloon injury of pig carotid arteries.

Circulation Research 1996; 79: 1177-87

16) Banning AP, Brewer L, Wendt M, Groves PH, Cheadle H, Penny WJ, Crawford N.

Locally delivery of platelets with encapsulated iloprost to balloon injured pig carotid arteries: effect on platelet deposition and neointima formation.

Thrombosis and Haemostasis 1997; 77: 190-6

17) Ferguson JD, Banning AP, Bashir Y.

A randomised comparison of temporary pacing using semi rigid and balloon flotation catheters.

Lancet 1997 :349; 1883

18) Mumford A, Banning AP.

Minimising delays to thrombolysis in patients developing myocardial infarction in-hospital.

Postgrad Med J 1997; 73: 491-5

19) Giddings JC, Banning AP, Ralis H, Lewis MJ.

Redistribution of von Willebrand factor (vWF) in porcine carotid arteries after balloon angioplasty.

Arterioscler, Thromb and Vasc Biol 1997 ; 17: 1872-8

20) Hanssen H, Brunini TMC, Conway M, Banning AP, Roberts NB,

Mann GE, Ellory JC, Mendes Ribero AC.

Increased L-arginine transport in human erythrocytes in chronic heart failure

Clin Sci 1997; 94: 43-8

21) Davies CH, Banning AP, Channon K, Ormerod OJ.

Left main coronary stenting for elderly patients unsuitable for bypass surgery.

Int J Cardiol 1997; 62: 13-18

22) Kelion A, Banning AP, Shahi M, Bell J.

Effect of the reduction of door-to-needle times on the administration of thrombolytic therapy for acute myocardial infarction.

Postgrad Med J 1998 ;74: 533-6

23) Orr WP, Banning AP

Aortic atheroma detected by transoesophageal echocardiography; a risk factor for cholesterol embolisation

Quart J Med 1999; 92: 341-6

24) Banning AP, Groves P, Buttery L, Wharton J, Rutherford RAD, Black P, Winkler F, Polak J, Lewis MJ, Drexler H

Reciprocal changes in endothelial and inducible nitric oxide synthase expression following carotid angioplasty in the pig

Atherosclerosis 1999;145: 17-32

25) Kelion A, Banning AP, Boulton B, Gribbin B

Coronary stenting in routine interventional practice

J R Coll Physicians London 1999; 33: 157-60

26) Banning AP, Prendergast BD

Intravenous L Arginine reduces the VE/VCO2 slope acutely in patients with chronic heart failure

European J Heart Failure 1999; 1:187-90

27) Gilbert TJ, Orr W, Banning AP

Aortic valve replacement in patients over 80 years of age: experience of a single UK centre

Heart 1999;82:138-42

28) Maher R, Philips Hughes J, Banning AP, Boardman P,

The frequency and significance of silent myocardial ischaemia due to hyoscine butylbromide use in peripheral angiography

Cardiovasc Intervent Radiol 1999 22:369-74

29) Kelion AD, Banning AP, Gardner MA, Ormerod OJ

Exercise radionuclide ventriculography predicts long term cardiac prognosis in patients with abdominal aortic aneurysm being considered for surgery.

J Nucl Cardiol 2000; 7: 249-54

30) Ferguson JD, Whatling PJ, Martin V, Walton J, Banning AP

Ultrasound guided percutaneous thrombin injection of iatrogenic pseudoaneurysms after coronary angiography and intervention

Heart 2001 ;85:E5

31) Kelion A, Webb T, Gardener MA, Ormerod OJ Banning AP

The warm up effect protects against ischaemic left ventricular dysfunction in patients with angina.

J Am Coll Cardiol 2001;37:705-710

32) Bowling A, Bond M, McKee D, McClay D, Banning AP, Dudley N, Elder A, Martin A, Blackman I.

Equity in access to exercise testing, coronary angiography, and CABG by age gender and clinical indications.

Heart 2001 ;85;680-6

33) Quantitative regional analysis of regional wall function

Jacobs G, Noble A, Kelion AD, Banning AP

Ultrasound in Med and Biology 2001 ;27: 773-784

34) Age and sex related bias in the management of heart disease in a distict general hospital.

Dudley N, Bowling A, Bond M, McKee D, McClay-Scott D, Banning AP, Elder A, Martin A, Blackman I.

Age and Ageing 2002 ;31:37-42

35) Kelion A, Webb T, Gardener MA, Ormerod OJ Shepherd GL, Banning AP

Does a selective adenosine A1 receptor antagonist protect against exercise induced in patients with coronary artery disease.

Heart 2002 ;87: 115-120

  • Blackman DJ, Clarke NC, Orr WP, Wilkinson E, Beswick A, Coppock D, Sprigings DC, Banning AP

Day case transfer for percutaneous coronary intervention with adjunctive abciximab in acute coronary syndromes

Heart 2002; 87: 375-6

37) A space shape based approach to tracking myocardial thickening and quantifying regional left ventricular function

Jacobs G, Noble JA, Behrenbuch C, Kelion AD, Banning AP

IEEE Trans Medical Imaging 2002; 21; 226-38

38) Ferguson JD, Orr WP, McKenna CJ, Blackman DJ, Channon KM, Forfar JC, Ormerod O, Banning AP

Percutaneous intervention in octogenarians with refractory angina

Heart 2002 88(1):85-6.

39) Alp N, West NEJ, Arnold N, Gunn J, Bannning AP, Channon KM

Increased intimal hyperplasia in experimental vein graft stenting compared with arterial stenting: comparisons in a new rabbit model of stent injury

Cardiovasc Res 2002; 56:164-72

40) Westaby S, Banning AP, Saito S, Pigott DW, Jin XY, Catarino PA, Robson D, Mooranji N, Kardos A, Poole-Wilson PA, Jarvik R, Frazier OH,

Circulatory support for long term treatment of heart failure. Experience with an intraventricular continuous flow pump.

Circulation 2002; 105:2588-91

41) Automated 3D echocardiography analysis compared with manual delineations and MUGA

Sanchez-Ortiz G, Wright GJ, Clarke N, DeClerk J, Banning AP Noble JA.

IEEE Trans Medical Imaging 2002 2002 ;9:1069-76

42) Bond M, Bowling A, McKee D, Kennelly M, Banning AP, Dudley N, Elder A, Martin A,

Does ageism affect the management of ischaemic heart disease?

J Health Services Research and Policy 2003;8 :40-7

43) Natural history of intramural haematoma of the descending aorta.

Timperley J, Ferguson JD, Niccoli G, Prothero A, Banning AP

Am J Cardiol. 2003; 9:777-80

44) Age and sex do not bias the use of Angiotensin-converting enzyme inhibitors in acute myocardial infarction and congestive heart failure.

Blackman IC, Bond M, Bowling A, Honmfphn, Banning A, Dudley N, Elder A, Martin A, Rai GS.

J Am Geriatr Soc 2003 ;51:572-3

45) Same-day discharge following elective percutaneous coronary intervention in patients with stable angina

Banning AP Ormerod OJ, Channon K, McKenna CJ, Orr W, Boulton B, Bashir Y, Forfar JC

Heart. 2003;89:665

Blackman IC, Bond M, Bowling A, Honmfphn, Banning A, Dudley N, Elder A, Martin A, Rai GS.

J Am Geriatr Soc 2003 ;51:572-3

46) A Randomized Study to Assess the Benefit of Paclitaxel-Eluting Stents for Coronary Revascularization using Two Different Release Kinetics in De Novo Coronary Lesions (TAXUS 2)

Colombo A, Drzewiecki J, Banning AP, Hauptmann K, Grube E, Dudek D, Fort S, Schiele S, Silber S, Zmudka Z, Guagliumi G, Russell ME

Circulation. 2003;108: 788-94.

47) Clarke NR, Timperley J, Kelion AD, Banning AP

Transthoracic echocardiography using second harmonic imaging with Valsalva manouvere for the detection of right to left shunts

Eur J Echocardiogr 2004 ; 5:176-81

48) Blackman D, Porto I, Shirodaria C, Channon KM, Banning AP

Usefulness of high pressure inflation to optimise deployment of drug eluting stents for the treatment of diffuse in stent coronary restenosis

Am J Cardiol 2004; 94: 922-5

49) Porto I, Blackman DJ, Nicolson D, Niccoli G, Kahn FZ, Omerod O, Forfar C, Channon K, Banning AP

What is the incidence of myocardial necrosis in elective patients discharged on the same day following coronary intervention


50) Selvanayagam JB, Kardos A, Nicolson D, Francis J, Petersen SE, Robson M, Banning AP, Neubauer S.

Anteroseptal or apical myocardial infarction: a controversy addressed using delayed enhancement cardiovascular magnetic resonance imaging.

J of Cardiovasc Magnetic Resonance 2004; 6: 653-661

  • Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, Figulla H, Drzewiecki J, Banning AP, Hauptmann K, Dudek D, Bruining N, Hamers R, Hoye A, Ligthart JM, Disco C, Koglin J, Russell ME, Colombo A

Incomplete Stent Apposition After Implantation of Paclitaxel-Eluting Stents or Bare Metal Stents. Insights from the Randomized TAXUS II Trial.

Circulation 2005:111 900-905

52) Selvanayagam JB; Porto I; Channon K;. Petersen SE. Francis JM; Neubauer S; Banning AP

Troponin Elevation Following Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible myocardial injury : Insights from Cardiovascular Magnetic Resonance Imaging

Circulation 2005 111:1027-32

53) Siegenthaler MP, Westaby S, Frazier OH, Martin J, Banning AP, Robson D, Pepper J, Poole-Wilson P, Beyersdorf F.

Advanced heart failure: feasibility study of long-term continuous axial flow pump support

Eur Heart J. 2005 ;26:1031-8

54) Porto I, Selvanayagam J, Ashar V, Neubauer S, Banning AP

Safety of magnetic resonance imaging one to three days after bare metal and drug eluting stent implantation

Am J Cardiol 2005; 96: 366-8

55) Porto I, Choudhury RP, Pillay P, Burzotta F, Trani C, Niccoli G, Blackman D, Channon KM, Banning AP

Filter no reflow during percutaneous coronary interventions using the FilterWire distal protection device

Int J Cardiol 2006:109 53-8

56) Selvanayagam JB; Herold J, Porto I; Cheng A, Channon K. Francis JM; Banning AP Neubauer S;

Resting Myocardial Blood Flow is Impaired in Hibernating Myocardium: An MR Study of Quantitative Perfusion Assessment

Circulation 2005; 112:3289-96

57) Blackman DJ, Choudhury R, Banning AP, Channon KM

Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts

J Invasive Cardiol 2005 (11):609-12

58) Gershlick AH, Stephens-Lloyd A,, Hughes S, Abrams K, Stevens SE, Uren N, de Belder A, Davis J, Pitt M, Banning AP, Baumbach A, Shiu MF, Schofield P, Dawkins K, Henderson R, Oldroyd K, Wilcox R.

Rescue Angioplasty Following Failed Thrombolysis for Acute Myocardial Infarction: The REACT Trial

NEJM 2005: 353: 2758-2768

59) Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, Redgrave JNE, Bull LM, Welch SMV, Cuthbertson FC, Binney L, Gutnikov SA, Anslow P, Banning AP, Mant D, Mehta Z.

Population-based study of event-rate, incidence, case fatality, mortality and projected future burden for all acute vascular events in all arterial territories: Oxford Vascular Study

Lancet 2005;366:1773-1784

60) Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ M, Koglin J, Russell ME

Clinical efficacy of polymer based paclitaxel eluting stents in the treatment of complex, long coronary artery lesions from a multicentre, randomized trial: support for the use of drug eluting stents in contemporary clinical practice

Circulation 2005 ;11;3306-13

61) Harney SM, Timperley J, Daly C, Harin A, James T, Brown MA, Banning AP, Fox K, Donnelly S, Wordsworth BP.

Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis

Ann Rheum Dis. 2006 ; 65:136.

62) Aoki J , Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, Schiele F, Russell ME, Koglin J, Serruys P

Peri-Stent Remodeling and Neointimal Suppression Two-Years after Polymer-Based, Paclitaxel-Eluting Stent Implantation -Insights from Serial IVUS Analysis in the TAXUS II Study

Circulation. 2005;112:3876-3883

63) Wehr G, Peters RJ, Khalife K, Banning AP, Kuehlkamp V, Rickards AF, Sechtem U.

A vector-based, 5-electrode, 12-lead monitoring ECG (EASI) is equivalent to conventional 12-lead ECG for diagnosis of acute coronary syndromes

J Electrocardiol. 2006 :39: 22-28

64) Percutaneous coronary intervention with stent deployment in anomalously-arising left circumflex coronary arteries.

West N, McKenna CJ, Ormerod OJ Forfar JC Banning AP, Channon KM

Catheterization and Cardiovascular Intervention 2006; 68; 882-90

65) Porto I, Selvanayagam SB, Van Gaal WJ, Prati F, Cheng A, Channon KM Neubauer S, Banning AP

Plaque volume and the occurrence and location of peri-procedural myocardial necrosis following PCI: Insights from delayed enhancement MRI, TIMI myocardial perfusion grade analysis and Intravascular Ultrasound

Circulation 2006 ; 114:662-669

66) Westaby S, Frazier OH, Banning AP.

Six years of continuous mechanical circulatory support

NEJM. 2006 ;355:325-7

67) Cheng AS, Pegg TJ, Karamitsos TD, Searle N, Jerosch-Herold M, Choudhury RP, Banning AP, Neubauer S, Robson MD, Selvanayagam JB.

Cardiovascular Magnetic Resonance Perfusion Imaging at 3 Tesla for the Detection of Coronary Artery Disease: A Comparison with 1.5 Tesla

J Am Coll Cardiol. 2007 ;49 :2440-9

68) Tuschida K, Serruys PW, Bruinning N, Dudek D, Drzewieki J, Banning AP Zmudka K, Scheile F, Zhou Z, Rademaker TAM, Gerit0- Anne, Koglin J, Rissell ME, Columbo A

Two year serial coronary angiographic and IVUS analyisof in stent angiographic late lumen loss and ultrasonic neoitimal volume form the TAXUS II trial

Am J Cardiol. 2007 ;99: 607-15

69) van Gaal WJ, Choudhury RP, Porto I, Channon K, Banning A, Dzavik V, Ramsamujh R, Bui S, Blackman DJ

Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts.
Am J Cardiol. 2007 ;99 :603-6.

70) Bermejo J, Timperley J, Odreman RG, Mulet M, Noble JA, Banning AP, Yotti R, Perez-David E,Declerck J, Becher H, Garcia-Fernandez MA.

Objective quantification of global and regional left ventricular systolic function by endocardial tracking of contrast echocardiographic sequences.
Int J Cardiol. 2008;124:47-56

71) Selvanayagam JB, Cheng ASH; Jerosch-Herold M, Porto I Rahimi K van Gaal W; Channon KM , NeubauerS

Banning AP

Effect of distal embolization on myocardial perfusion reserve following percutaneous coronary intervention: A Quantitative MR Perfusion Study

Circulation 2007;116 1458-1464

72) Dawson D, Clarke N, Banning AP
Management of the Ascending Aortic Pseudoaneurysms – a single centre experience

Int J Cardiol 2008;130:92-5

73) Schrale R , Van Gaal W, Channon KM Forfar JC Ormerod OJ, Banning AP

Long-term Outcomes of Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease

Int J Cardiol 2008;130:185-9

74) Arnold R, Karamitsos T, Shirodaria C,Banning AP

Should patients undergoing PCI still be consented for emergency bypass?

Int J Cardiol 2009;132:447-8

75) van Gaal WJ, Arnold JR, Porto I, Jennings B, Ashar V, Schrale RG, Banning AP

Long term outcome of elective day case percutaneous coronary intervention in patients with stable angina

Int J Cardiol 2008;128:272-4

76) Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ M, Koglin J, Russell ME

Safety and efficacy of multiple, overlapping polymer based paclitaxel eluting stents

Euro Intervention 2007;3:213-221

77) Grube E, Dawkins KD, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ Bellsfield M, Koglin J, Russell ME

TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.
Eur Heart J. 2007: 21:2578-82

78) Cheng AH, Selvanayagam J Jerosch-Herold M, van Gaal WJ, Karamitso T, Neubauer S, Banning AP

Percutaneous Treatment of Chronic Total Coronary Occlusions Improves Regional Hyperaemic Myocardial Blood Flow and Contractility: Insights from Quantitative Cardiovascular Magnetic Resonance Imaging

JACC Cardiovasc Intv, 2008; 1:44-53

79) Testa L, Van Gaal WJ, Bhindi R, Biondi-Zoccai GG, Abbate A, Agostoni P, Porto I, Andreotti F, Crea F,

Banning AP.

Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients.

J Thorac Cardiovasc Surg. 2008 ;136 :884-93.

80) Testa L, Van Gaal WJ, Biondi-Zoccai, A Abbate A, Agostoni P, Bhindi R, Banning AP

Repeat Thrombolysis or Conservative Therapy versus Rescue Percutaneous Coronary Intervention for Failed Thrombolysis: Systematic Review and Meta-Analysis

Quarterly J Medicine. 2008 ;101:387-95

81) Gough MJ, Bodenham A, Horrocks, Colam B, Lewis SC, Rothwell P, Banning AP, Torgerson T, Gough M, Dellagrammaticas D, Leigh-Brown A, Liapis C, Warlow C

GALA: an international multicentre randomised trial comparing general anaesthesia versus local anaesthesia for carotid surgery

Trials 2008; 9:28

82) Van Gaal W, Ponnutharoi FA, Selvanayagam J, Testa L, Porto I , Neubauer S, Banning AP

The Syntax Score Predicts Peri-procedural Myocardial Necrosis during Percutaneous Coronary Intervention.

Int J Cardiol 2008; 135: 60-5

83). Karamitsos TD, Arnold JR, Pegg TJ, Cheng AS, van Gaal WJ, Francis JM, Banning AP, Neubauer S, Selvanayagam JB

Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease.

Int J Cardiovasc Imaging. 2009 ;25; 277-83

84) Lewis SC, Warlow CP, Bodenham AR, Colam B, Rothwell PM, Torgerson D, Dellagrammaticas D, Horrocks M, Liapis C, Banning AP, Gough M, Gough MJ.

General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial

Lancet. 2009 20;372 :2132-42

85) Banerjee A, Silver LE , Heneghan C, Welch SJV, Bull LM, Mehta Z, Banning AP, Rothwell PH

Sex-specific familial clustering of myocardial infarction in patients with acute coronary syndromes

Circ Cardiovasc Genet. 2009;2:98-105

86) Grube E, Dawkins KD, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns Joshi A, Mascioli S

TAXUS VI final 5 year results : a multicentre trial comparing polymer based moderate release Paclitaxel eluting stents with a bare metal treatment of long, complex lesions.
Eurointervention 2009; 4:572-7

87) Testa L, Van Gaal WJ, Bhindi R, Biondi Zoccai , Agostoni P, Latini RA, Bedagani F, Porto I, .Banning AP

Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition

Quarterly J Medicine 2009;102:369-78

88) Rahimi K, Banning AP, Cheng AS, Pegg TJ, Karamitsos TD, Channon KM, Darby S, Taggart D, Neubauer S, Selvanayagam JB

Prognostic Value of Coronary Revascularisation Related Myocardial Injury: A Cardiac Magnetic Resonance Imaging Study.

Heart 2009;95:1937-1943.

89) Silber S, Colombo A, Banning AP, Hauptmann K, Drzewiecki, J, Grube G, Dudek D, Baim DM.

The Final 5-Year Results of the TAXUS II Trial: A Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for de Novo Coronary Artery Lesions

Circulation 2009;120 1498-1504

90) Banning AP, Westaby S, Morice MC, Kappetein AP, Mohr FW, Berti S, Glauber M, Kellett MA, Kramer RS Leadley K, Dawkins KD, Serruys PW

Comparison of Cardiac Surgery and Paclitaxel-Eluting Stents in Nondiabetic and Diabetic Patients with Left Main and or 3 vessel coronary artery disease

J Am Coll Cardiol. 2010; 55:1067-1075

91) Testa L, Agostoni P, Vermeersch P, Biondi Zoccai G, Van Gaal W, Bhindi R, Brilakis E, Latini R, Laudisa ML, Pizzocrii S, Lanotte S, Brammbilla N, Banning AP, Bedogoni F

Drug eluting stent versus bare metal stent in the treatment of saphenous vein graft disease.  A systematic review and meta-analysis

EuroIntervention 2010;6:527-536

92) Van Gaal W, Arnold J, Testa L, Karamistos T, Ponnuthurai F, Lim C, Petersen S, Francis J, Selvanayagam J, Sayeed R, West N, Westaby S, Neubauer S, Banning AP

Myocardial Injury following Coronary Artery Surgery versus Angioplasty A Randomized Trial Using Biochemical Markers and Cardiac Magnetic Resonance Imaging (MICASA)

EuroIntervention. 2011;6:703-10.

93) Lim C, Van Gaal W, Testa L, Cucculi F, Arnold R, Karamistos T, Francis J Petersen S, Digby J, Westaby S, Antoniadis C, Kharbanda R, Burrell L, Neubauer S, Banning AP

Using the “universal definition”, measurement of CKMB rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention

J Am Coll Cardiol 2010 57:653-61.

94) Stent thrombosis, major bleeding and antiplatelet therapy in the e-SELECT registry

Urban P, Abizaid A, Banning AP, Bartorelli AL, Dvavik V, Ellis SG, Gao R, Holmes D, Jeong J, Legrand V, Neumann F, Nyakern M, Spaulding C, Stoll HP, Worthley S

J Am Coll Cardiol. 2011;57:1445-54.

95) Familial history of stroke is associated with acute coronary syndromes in women

Bannarjee A, Lim CC, Silver L, Welch SJV, Banning AP, Rothwell P

Circ Cardiov Genetics 2011:4;9-15

96) Arnold R , Francis J, Karamistos T, Lim C, Van Gaal W, Testa L, Bhama –Azira , Selvanayagam J, Sayeed R,

Westaby S, Banning AP, Neubauer S , Jerosch Herold M.

Myocardial perfusion imaging following Coronary artery bypass surgery suing cardiac magnetic resonance : a validation study

Circ Cardiovasc Imaging. 2011:312-8

97) Dall’armellina E, Karia N, Lindsay AC, Karamitsos TD, Ferreira V, Robson MD, Kellman P, Francis JM, Forfar C, Prendergast B, Banning AP, Channon KM, Kharbanda R, Neubauer S, Choudhury R

Dynamic Changes of Edema and Late Gadolinium Enhancement after Acute Myocardial Infarction Relationship to Functional Recovery and Salvage Index

Circ Cardiovasc Imaging 2011:4;228-36

98) Lim C, Cucculi F, Van Gaal W, Testa L, Arnold R, Karamistos T, Francis J , Digby J, S, Antoniadis C, Kharbanda R, Neubauer S, Westaby S, Banning AP

Diagnosis of Peri-operative Myocardial Infarction After Coronary Bypass Surgery: A Study Using Biomarkers and Cardiac MRI

Ann Thorac Surg. 2011 Dec;92(6):2046-53

Reply to letter Banning AP

Ann Thorac Surg. 2012 Sep;94(3):1036.

99) Mack M, Banning AP, Serruys PW, Mohr F, Morice MC, Mohr FW, Taeymans Y, Van Nooten G, Possati, G, Crea, F, Hood, KL, Leadley K, Dawkins KD, Kappetein AP

Treatment of Complex Coronary Artery Disease in Patients with Diabetes and Metabolic Syndrome: 3-Year Results Comparing Outcomes of Cardiac Surgery and Percutaneous Coronary Intervention in the SYNTAX Study

Ann Thorac Surg. 2011 Dec;92(6):2140-6.

100) Banerjee A, Silver LE , Heneghan C, Welch SJV, Mehta Z, Banning AP, Rothwell PH

Relative familial clustering of cerebral versus coronary ischaemic events

Circ Cardiovasc Genet. 2011 ;4: 390-6.

101) Gao R, Abizaid A, Banning AP, Bartorelli AL, Dvavik V, Ellis SG, Holmes D, Jeong J, Legrand V, Neumann F, Nyakern M, Spaulding C, Stoll HP, Worthley S, Urban P

Sirolimus-Eluting Coronary Stents in Octogenarians A 1-Year analysis of the worldwide e-Select registry

JACC Cardiovasc Intv, 20011 ; 4 :982-991

102) Cuculi F, Banning AP Abizaid , Bartorelli AL, Baux B, Dvavik V, Ellis SG, Gao R, Holmes D, Jeong J, Legrand V, Neumann F, Nyakern M, Spaulding C, Stoll HP, Worthley S, Urban P

Outcomes In Patients Undergoing Multi-Vessel Percutaneous Coronary Intervention using Sirolimus Eluting Stents – A report from the e-SELECT registry.

Eurointervention 2011 ;7: 962-8

103) Cuculi F, Lim C, ,Van Gaal W, Testa L, , Westaby S, Arnold R, Neubauer S, Banning AP

Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting.

CardioVasc Thorac Surg 2011;13:585-590

104) Arnold R , Karamistos T, Bhama –Azira P Francis J, Searle N, Robson , Howells Choudhury R, Rimoldi OE, Camicic P, Banning AP, Neubauer S , Jerosch Herold M. Selvanayagam J,

Myocardial Oxygenation in Coronary Artery Disease: Insights from Blood Oxygen Level-Dependent Magnetic Resonance Imaging at 3-Tesla

J Am Coll Cardiol. 2012 ;59:1954-64.

105) Abizaid Costa J,, Banning AP , Bartorelli AL, Baux B, Dvavik V, Ellis SG, Gao R, Holmes D, Jeong J, Legrand V, Neumann F, Nyakern M, Orlick , Spaulding C, Worthley S, Urban P The Sirolimus-Eluting Cypher Select Coronary Stent for the Treatment of Bare-Metal and Drug-Eluting Stent Restenosis Insights From the e-SELECT (Multicenter Post-Market Surveillance) Registry

JACC Cardiovasc Intv, 20012 ; 5 : 64-71

106) Dall’armellina E, Piechnik SK, Si SL, Robson MD, Francis JM, Cuculi F, Kharbanda R, Banning AP, Choudhury R, Karamitsos TD, Neubauer S,

Cardiovascular magnetic resonance by non contrast T1 mapping allows assessment of severity of injury in acute myocardial infarction

Journal of Cardiovascular Magnetic Resonance 2012, 14:15

107) Worthley SG, Abizaid A, Banning A, Bartorelli A, Džavík V, Ellis S, Gao R, Legrand V, Urban P, Spaulding C; for the e-SELECT investigators.

One-Year Clinical Outcomes after Sirolimus-Eluting Coronary Stent Implantation for Acute Myocardial Infarction in the Worldwide e-SELECT Registry.

J Interv Cardiol. 2012 (3):253-61

108) Banerjee A, Lim CC, Silver LE, Heneghan C, Welch SJ, Mehta Z, Banning AP, Rothwell PM.

Family history does not predict angiographic localization or severity of coronary artery disease.

Atherosclerosis. 2012 Apr;221(2):451-7

109) Myerson SG, d’Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM, Banning AP, Christiansen JP, Neubauer S

Clinical Outcome in Aortic Regurgitation with Cardiovascular Magnetic Resonance.

Circulation. 2012 Sep 18;126(12):1452-60.

110) Gao R, Abizaid A, Banning AP, Bartorelli A, Džavík V, Ellis S, Jung LH, Legrand V, Spaulding C Urban P; for the e-SELECT investigators.

One-year outcome of small-vessel disease treated with sirolimus-eluting stents: a subgroup analysis of the e-SELECT registry.

J Interv Cardiol. 2012 26(2):163-72.

111) Leone AM, de Caterina AR, Basile E, Gardi A, Laezza D, Mazzari MA, Mongiardo R, Kharbanda R, Cuculi F, Porto I, Burzotta F, Trani C, Banning AP, Rebuzzi AG, Crea F.

Influence of the amount of myocardium subtended by a stenosis on Fractional Flow Reserve

Circ Cardiovasc Interv. 2013;6:29-36

112) Cucculi F, Herring N, De Caterino A , Banning AP, Prendergast B, Forfar C, Channon KM, Choudhury R, Kharbanda R

Relationship of plasma Neuropeptide-Y with angiographic, electrocardiographic, and coronary physiology indices of reperfusion during ST-elevation myocardial infarction.

Heart 2013; 99: 1198-203

113) Kappetein AP , Head S, Morice MC, Banning AP, Serruys PW, Mohr F, Dawkins KD, Mack MJ on behalf of the Syntax investigators

Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial

Eur J Cardiothorac Surg. 2013; ;43(5):1006-13

114) Arnold RJ, Karamistos T, Van Gaal W, Testa L , Francis J , Bhamra-Ariza B, Ali A, Selvanayagam J, Westaby S, Sayeed R, Jersoch- Herold M, Neubauer S, Banning AP

Residual ischaemia following revascularization in multivessel coronary disease : insights from measurement of absolute myocardial blood flow using magnetic resonance imaging compared with angiographic assessment

Circ Cardiovasc Interv. 2013; ;6 (3):237-45

115) Sabate M, Bruggaletta S, Abizaid A, Banning AP, Bartorelli A, Džavík V, Ellis S, Holmes D, Gao R, Jung LH, Legrand V, Neuman F, Spaulding C,Stoll P, Urban P

Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry

Int J Cardiol. 2013 ;168 (3):2522-7.

116) Meredith IT, Verheye S, Weissman NJ, Barragan P, Scott D, Chávarri V, West NE, Kelbæk H, Whitbourn R, Walters DI, Kubica J, Thuesen L, Masotti M, Banning AP, Sjögren I, Stables RH, Allocco DJ, Dawkins KD

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Eurointervention 2013; 9 : 308-15

117) Kassimis G, Patel N, Kharbanda R, Channon K, Banning AP

High Speed Rotational Atherectomy using the radial artery approach and a sheathless guide: a single centre comparison with conventional femoral approach

Eurointervention 2013

118) Cuculi F, Dall’armellina E, Manlhiot C, De Caterina AR, Colyer S, Ferreira V, Morovat A, Prendergast BD, Forfar JC, Alp NJ, Choudhury RP, Neubauer S, Channon KM,. Banning AP, Kharbanda RK

Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-Elevation myocardial infarction

Eur Heart J. 2014 Aug 1;35(29):1971-80.

119) Curzen N, Rana O, Nicholas Z, Golledge P, Zaman A, Oldroyd K, Hanratty C, Banning AP, Wheatcroft S, Hobson A, Chitkara K, Hildick-Smith D, McKenzie D, Calver A, Dimitrov BD, Corbett S

Does Routine pressure wire assesment influence management strategy at coronary angiography for diagnosis if chest pain? The RIPCHORD study

Circ Cardiovasc Interv. 2014 Apr;7(2):248-55

120) Leone AM, De Caterina AR, De Maria GL, Scalone G, Tagliaferro F, Gardi A, Clemente F, Laezza D, Basile E, Cialdella P, Aurigemma C, Porto I, Burzotta F, Niccoli G, Trani C, Rebuzzi AG, Banning AP, Crea F.

Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis.

EuroIntervention. 2015 Jul 22;11(3):308-18.

121) Zhang YJ1, Iqbal J, Campos CM, Klaveren DV, Bourantas CV, Dawkins KD, Banning AP, Escaned J, de VriesT, Morel MA, Farooq V, Onuma Y,Garcia-Garcia HM, Stone GW, Steyerberg EW, Mohr FW, Serruys PW1

Prognostic Value and Clinical Implication of the ‘Site’ SYNTAX Score: 5-Year Follow-Up of the SYNTAX Trial

J Am Coll Cardiol. 2014 Aug 5;64(5):423-32

122) Patel N, De Maria GL, Kassimis G, Rahimi K, Bennett D, Ludman P, Banning AP

Outcomes after emergency Percutaneous intervention in patients with unprotected left main occlusion : the BCIS national audit of PCI outcomes 6 year experience

J Am Coll Cardiol Interv 2014;7:969-80

123) Cuculi F, De Maria GL, Meier P, Dall’Armellina E, de Caterina AR, Channon KM, Prendergast BD, Choudhury RC, Forfar JC, Kharbanda RK, Banning AP.

Impact of Microvascular Obstruction on the Assessment of Coronary Flow Reserve, Index of Microcirculatory Resistance, and Fractional Flow Reserve After ST-Segment Elevation Myocardial Infarction.

J Am Col Cardiol 2014 64(18):1894-904

124) De Maria GL, Burzotta F, Trani C, Kassimis G, Pirozzolo G, Patel N, Dato I, Porto I, Leone AM, Niccoli G, Kharbanda R, Crea F, Banning A

Trends and outcomes of radial approach in left main bifurcation percutaneous coronary intervention in the drug-eluting stents era: a two-centre registry

J Invasive Cardiol. 2015 Jul;27(7):E125-36

125) Zhang YJ, Iqbal J, van Klaveren D, Campos CM, Holmes DR, Kappetein AP, Morice MC, Banning AP, Grech ED, Bourantas CV, Onuma Y, Garcia-Garcia HM Mack MJ, Colombo A, Mohr FW Steyerberg EW, Serruys PW

Smoking Is Associated With Adverse Clinical Outcomes in Patients Undergoing Revascularization With PCI or CABG: The SYNTAX Trial at 5-Year Follow-Up.

J Am Col Cardiol 2015 Mar 24;65(11):1107-15

126) Bull S, Loudon M, Francis JM, Joseph J, Gerry S, Karamitsos TD, Prendergast BD, Banning AP, Neubauer S, Myerson SG

A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial)

Eur Heart J Cardiovasc Imaging. 2015 Aug;16(8):834-41

127) Iqbal J, Zhang YJ, Holmes DR, Morice MC, Mack MJ, Kappetein AP, Feldman T, Stahle E, Escaned J, Banning AP, Gunn JP, Colombo A, Steyerberg EW, Mohr FW, Serruys PW.

Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: Insights from the SYNTAX trial at 5-year follow-up

Circulation. 2015;131(14):1269-77

128) Bartorelli A, Assenza GE, Abizaid A, Banning AP, Džavík V, Ellis S, Gao R, Holmes D, Jung LH, Legrand V, Neuman F, Spaulding C,Worthley S,Urban P

One-Year Clinical Outcomes After Sirolimus-Eluting Coronary Stent Implantation in Diabetics Enrolled in

the Worldwide e-SELECT Registry

Catheter Cardiovasc Interv 2015

129) Taggart DP, Ben Gal Y, Lees B, Patel N, Webb C, Rehman SM, Desouza A, Yadav R, De Robertis F, Dalby M, Banning A, Channon KM, Di Mario C, Orion E.

A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.

Ann Thorac Surg. 2015 Apr 15. pii: S0003-4975(15)00206-4.

130) Ruparelia N, Godec J, Lee R, Chai JT, Dall’Armellina E, McAndrew D, Digby JE, Forfar JC, Prendergast BD, Kharbanda RK, Banning AP, Neubauer S, Lygate CA, Channon KM, Nicholas Haining W, Choudhury RP.

Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humans.

Eur Heart J. 2015 Aug 1;36(29):1923-34

131) Campos CM, Stanetic BM, Farooq V, Walsh S, Ishibashi Y, Onuma Y, Garcia-Garcia HM, Escaned J, Banning A, Serruys PW; SYNTAX II Study Group.

Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.

Catheter Cardiovasc Interv. 2015 May 6

132) Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschöpe C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Böhm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KE, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Lüscher TF.

Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy

N Engl J Med. 2015 Sep 3;373(10):929-38.

133) Patel N, Petraco R, Dall’Armellina E, Kassimis G, De Maria GL, Dawkins S, Lee R, Prendergast BD, Choudhury RP, Forfar JC, Channon KM, Davies J, Banning AP, Kharbanda RK

Zero-Flow Pressure Measured Immediately After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Provides the Best Invasive Index for Predicting the Extent of Myocardial Infarction at 6 months: an OXAMI study

JACC Cardiovasc Interv. 2015 Sep;8(11):1410-21

134) De Maria GL, Cuculi F, Patel N, Dawkins S, Fahrni G, Kassimis G, Choudhury RP, Forfar JC, Prendergast BD, Channon KM, Kharbanda RK, Banning AP

How does coronary stent implantation  impact on the status of the microcirculation during primary percutaneous intervention in patients with ST elevation myocardial infarction?

Eur Heart J. 2015 Aug 7. pii: ehv353. [Epub ahead of print]

135) Rampat R, Khawaja MZ, Byrne J, MacCarthy P, Blackman DJ, Krishnamurthy A, Gunarathne A, Kovac J, Banning A, Kharbanda R, Firoozi S, Brecker S, Redwood S, Bapat V, Mullen M, Aggarwal S, Manoharan G, Spence MS Khogali S, Dooley M, Cockburn J, de Belder A, Trivedi U, Hildick-Smith D

Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Valve: United Kingdom Experience.

JACC Cardiovasc Interv. 2016 Feb 22;9(4):367-72

136) Escaned JBanning AFarooq VEchavarria-Pinto MOnuma YRyan NCavalcante RCampos CMStanetic BMIshibashi YSuwannasom PKappetein APTaggart DMorel MAvan Es GASerruys PW.

Rationale and Design of the SYNTAX II Trial: Evaluating the Short to Long Term Outcomes of State-of-the-Art Percutaneous Coronary Revascularization in Patients with De Novo Three Vessel Disease

Eurointervention 2016;12(2):e224-34

1) Banning AP, Ruttley MST, Musumeci F, Fraser AG.

Acute dissection of the thoracic aorta. (Editorial)

Br Med J 1995; 310: 72-3.

2) Newby AC, Fabunmi RP, George SJ, Southgate KM, Banning AP, Thurston VJ, Williams A.

Growth factors and metalloproteinases mediate the vascular smooth muscle cell proliferation that initiates neointimal fibrosis in vascular pathologies.

Experimental Nephrology 1995; 3: 108-13

3) Prendergast BD, Banning AP, Hall RJC

Valvular heart disease: recommendations for investigation and management. Summary of guidelines produced by a working group of the British Cardiac Society and Research Unit of the Royal College of Physicians.

J R Coll Physicians London 1996; 30:309-315

(letters – in response)

J R Coll Physicians London 1997; 31: 113-4

J R Coll Physicians London 1996; 30: 589-90

4) Banning AP, Hall RJC.

Assesment of competence of trainees in the medical specialties

Brit J Hosp Med 1996 ; 56: 588-9

5) Banning AP, Orr W.

Treatment of aortic dissection (Review)

Contemporary treatments in Cardiovascular Disease 1997; 2: 101-116

6) Banning AP, Orr W, Gribbin B.

Cholesterol embolisation. (Editorial)

Heart 1998; 79: 113-4

7) Banning AP, Pillai R.

Non penetrating cardiac and aortic trauma (Review)

Heart 1997; 78 :226-9.

8) Kelion AD, Banning AP, Ormerod OJ

Does exercise radionuclide ventriculography still have a role in clinical cardiac assessment ? (Review)

J Nuclear Cardiology 1999;6:540-6

9) Channon K, Banning AP

Echocardiography in stroke and thromboembolism: transoesophageal echocardiography for all? (Review)

Quarterly Journal of Medicine 1999;92 :619-21

10) Kelion AD, Banning AP

Is simple clinical assessment adequate for cardiac risk assessment before elective non-cardiac surgery (Commentary)

Lancet 1999;354:1837-8

11) Alp N, Clarke N, Banning AP

How should patients with patent foraman ovale be treated? (Editorial)

Heart 2001;85:242-5

12) Niccoli G, Banning AP

Heparin dose during PCI: how low dare we go? (Viewpoint)

Heart 2002;88:331-4

13) Blackman D, Ferguson J, Sprigings D, Banning AP

Revascularisation for acute coronary syndromes in older people-a systematic review

Age and Ageing 2003; 32:129-35

14) Banning AP, Hougton P

Post Hospital Care of the Permanent LVAD Patient.
ASAIO J. 2005;51(6):xxi-xxiii.

15) Mitchell A, Timperley J, Banning AP.

Acute thoracic aortic syndromes: Learning module Heart (accessed 22.05.06)

  • Ryding AS, Banning AP

Which patients on warfarin can be safely treated with a drug eluting stent (Viewpoint)

Heart 2008; 94: 275-77

17) Van Gaal W, Banning AP

Percutaneous coronary intervention and the no-reflow phenomenon.
Expert Rev Cardiovasc Ther. 2007 :715-731.

18) Arnold R West NJ, Van Gaal W, Karamistos T, Banning AP

The role of Intravascular Ultrasound in the management of spontaneous coronary artery dissection (Review)

Cardiovascular Ultrasound 2008, 6:24

19) Bhindi R, Ormerod O, Newton J, Banning AP, Testa L

Interaction between statins and clopidogrel: is there anything clinically relevant?

Quarterly J Medicine 2008;101:915-25

20) Cuculi F, Lim C, BanningAP

Periprocedural myocardial injury during elective percutaneous coronary intervention – Is it important and how can it be prevented? (Review)

Heart 2010;96 736-740

21) Cucculi F, Lim C , BanningAP

Takutsobo Cardiomyopathy (Editorial)

Brit Med J 2010 c1272

22) Testa L, Bhindi R, Van Gaal WJ, Latini RA, Pizzocri S, Lanotte S, Biondi Zoccai GG, Valgimigli M, Laudisa ML, Brambilla N, Banning AP, Bedogni F.

What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel

QJM. 2010 ;103 :367-77

23) Lim C Banning AP,

Drug Eluting Balloons – what is their place on the interventionalist’s shelf? (Editorial)

Heart 2010 ; 96: 1257-1258

24) Niccoli G, Crea F, Kharbanda R, Banning AP

No-reflow: again prevention is better than treatment (Viewpoint)

Eur Ht J 2010 :31(20) 2449-55

25) Rahimi K, Malhotra A, Banning AP, Jenkinson C

Outcome selection and role of patient-reported outcomes in contemporary cardiovascular trials: a systematic review

Brit Med J. 2010 ;341:c5707. doi: 10.1136/bmj.c5707.

26) Adlam D, Cucculi F, Lim C Banning AP,

Management of Spontaneous Coronary Artery Dissection in the primary percutaneous coronary intervention era (review)

J Invasive Cardiology 2010 22 (11) 549-53

  • Van Gaal W, Banning AP,

Lessons from MICASA A Randomized Trial Using Biochemical Markers and Cardiac Magnetic Resonance Imaging.

Interventional Cardiology 2011:3 283-289 

28) Banning AP

Should stent selection in diabetic patients be considered as a special case? (editorial)

Eurointervention 2011; 3: 297-99

29) Taggart DP, Banning AP

Stents and failing vein grafts: are we any wiser after ISAR? (Commentary)

Lancet 2011 378(9796):1054-5

30) Cuculi F, AR De Caterina, Kharbanda R, Banning AP

Optimal reperfusion in ST elevation myocardial infarction- role of the microcirculation (review)

Swiss Med Wkly. 2011 Dec 9;141:w13313. doi: 10.4414/smw.2011.13313.

31) Westaby S, Kharbanda R , Banning AP

Cardiogenic Shock In ACS . part I prediction, presentation and medical therapy (review)

Nat Rev Cardiol. 2011 Dec 20;9(3):158-71.

32) De Caterina AR, Porto I, De Maria GL, Banning AP.

Prevention and Treatment of Coronary Distal Embolization in the Setting of Acute Myocardial Infarction: Pharmacologic Approach. (review)

Curr Vasc Pharmacol. 2012 Jul;10(4):463-7.

33) Banning AP, Hood KL, Finn AV. Patterson C, Abizaid A, Eppiher MJ, Dawkins K, Baim DS.

Differential drug eluting stent effects in patients with diabetes-bench to bedside evidence for neointimal suppresion and restenosis reduction

Interventional Cardiology 2010;5: 27-34

34) Banning AP

“The view from the interventionalist”: 2nd Strategic Meeting, EACTS, Windsor 2012

Eur J Cardiothorac Surg. 2013 Jan ;43 (1):250-1

35) Patel N, Cuculi F, Kharbanda R, Banning AP

How do we optimise myocardial perfusion in STEMI (review)

Cardiology International 2012;13 (3) 99-104

36) De Caterina AR, Cuculi F, Banning AP

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents

Eurointervention 2013; 8:1326-34

Protecting the heart: Biological targets and clinical strategies (review)

Curr Pharm Des 2012; 19; 4529-43

  • Patel N, Banning AP

Bioabsorbable scaffolds for the treatment of obstructive coronary artery disease – the next revolution in coronary intervention? (review)

Heart 2013; 99 1236-43

39) Gershlick AG, Banning AP, Myat A, Verheugt FWA, Gersh BJ

Reperfusion therapy for STEMI: is there a role for thrombolysis in the era of primary percutaneous coronary


Lancet 2013; 382; 624-32

40) De Maria GL, Kassimis G, Patel N, Banning AP

Spontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis and prevention (review)

Scientifica 2013 2013:364247

41) Niccoli G, Sgueglia GA, Montone RA, Roberto M, Banning AP, Crea F

Evolving management of patients treated by drug-eluting stent:  prevention of late events.

Cardiovascular Revascularization Medicine 2014

42) Kassimis G, De Maria GL, Patel N, Banning AP

Myocardial Revascularization Strategies in Diabetic Patients with Multi-Vessel Disease: CABG vs DES-Based PCI

Curr Pharm Des. 2014;20(28):4589-96. Review.

43) Kassimis G, De Maria GL, Patel N, Banning AP

Evolution of coronary stents in patients with diabetes: are clinical outcomes still improving?

Expert Rev Cardiovasc Ther. 2014 Aug;12(8):997-1003

44) Myat A, Patel N, Tehrani S, Banning AP, Redwood SR Bhatt DP

Percutaneous Circulatory Assist Devices for High-Risk Coronary Intervention

JACC Cardiovasc Intv 2015 :8 : 2 2 9 – 4 4

45) De Maria GL, Banning AP, Porto I

Should we reserve mechanical thrombectomy to patient with short (or long) ischemic time? A critical view at the data Interventional Cardiology 2015

46) Banning AP, Baumbach A, Blackman D, Curzen N, Devadathan S, Fraser D, Ludman P, Norell M, Muir D, Nolan J, Redwood S; British Cardiovascular Intervention society

Percutaneous coronary intervention in the UK: recommendations for good practice 2015.

Heart. 2015 May;101(Suppl 3):1-13. doi: 10.1136/heartjnl-2015-307821

47) Kassimis G, Davlouros P, Patel N, De Maria G, Kallistratos MS, Kharbanda RK, Manolis AJ, Alexopoulos D, Banning AP

Adenosine as an adjunct therapy in ST elevation myocardial infarction patients: myth or truth

Cardiovascular Drugs and Therapy 2015

48) Kassimis G1Channon KMHahalis GPoulimenos LManolis ABanning APKrokidis M

Transradial arterial access catheter Knots : how top stay out of trouble

Minerva Cardioangiol 2015

49) De Maria GL, Fahrni G, Banning AP

The temporal recovery of fractional flow reserve, coronary flow reserve and index of microcirculatory resistance following myocardial infarction

Curr Opin Cardiol 2015

50) Dawkins S, Curzen N, Banning A.

Out of hospital Cardiac arrest: should everybody go to the cath lab?

Postgrad Med J 2016 ] doi:10.1136/postgradmedj-2015-133421

51) Lassen JF1, Holm NR, Banning A, Burzotta F, Lefèvre T, Chieffo A, Hildick-Smith D, Louvard Y, Stankovic G.

Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club.

EuroIntervention. 2016 ;12 (1): 38-46

52) De Maria G. Kassimis G, Raina T, Banning AP

Reconsidering the back door approach by targeting the coronary sinus in ischaemic heart disease


53) Kassimis G, Banning AP

Is it time to take bare metal stents of the catheter laboratory shelf?

European Heart J

54)Wolfrum M: Fahrni G; de Maria GL; Knapp G; Curzen N; Kharbanda R; Froehlich GM; Banning AP

Impact of impaired fractional flow reserve after coronary interventions on outcomes: a systematic review and meta-analysis

BMC Cardiovascular Disorders

1) Banning AP, Brook G, Bannister BA.

Detection of antihepatitis C antibody in severe Ebstein Barr virus-induced hepatitis.

J Infect 1991; 22:298-299

2) Banning AP, Avery PA, McGurk L, Fraser AG, Buchalter MB.

Recommendations for pacing. (letter)

Br Med J 1992; 305:1431-1432

3) Lewis NP, Banning AP, Penny WJ.

Coronary artery fistula and unstable angina complicating post transplantation surveillance right ventricular endomyocardial biopsy.

J Heart Lung Transplant 1994; 13: 929-30.

4) Ferguson JD, Moore N, Banning AP.

Intramural aortic haematoma causing ischaemia of the spinal chord.

Heart 1996; 75: 533

5) Banning AP

Imaging the thoracic aorta. (letter)

Heart 1997; 77: 87

6) Banning AP, Durrani A, Pillai RP.

Rupture of the atrial septum and tricuspid valve following blunt chest trauma

Ann of Thoracic Surg 1997; 64: 240-2

7) Banning AP

Aortic intramural haematoma (letter)

N Engl J Med 1997; 337: 1476-7

8) Banning AP

Primary angioplasty and stenting of left main coronary occlusion

Heart 1998 ; 79: 528-9

9) Channon KM, Banning AP, Davies CH, Bashir Y.

Coronary artery aneurysm rupture mimicking dissection of the thoracic aorta

Int J Cardiol 1998 ;65: 115-7

10) Kelion A, Banning AP

Screening with exercise thallium after coronary artery bypass grafting (letter)

Lancet 1998; 351: 1585

11) Porter J, Banning AP

Intrapleural streptokinase (letter).

Thorax 1998; 53: 720

12) Farmery AD, Chambers PH, BanningAP

Delayed rupture of the mitral valve complicating blunt chest trauma

J Accid Emerg Med 1998; 15: 422-3

13) Pantaleo P, Prothero AP, Banning AP

Aorto-bronchial fistula resulting from an accidental fall one year earlier.

Int J Cardiol 1999 ; 68: 239-40

14) Fox AD, Banning AP, Channon K, Hands L

Saddle embolism of the carotid bifurcation. A late complication of mediastinal radiotherapy

Eur J Vasc Endovasc Surg 1999; 17: 360-2

15) Musialek P, Kardos A, Banning AP

Myocardial infarction in young people with normal coronary arteries (letter)

Heart 1999; 81:451

16) Banning AP

Salvage angioplasty/stenting following spontaneous dissection of the left anterior descending coronary artery

Heart 1999;82:e6

17) Porter JN, Pillai R, Banning AP

Management of a Left Atrial Mass in an Octogenarian.

Age and Ageing 1999

18) Adlam D, Firoozan S, Gribbin B, Banning AP

Haemorrhagic cystitis following parenteral peniclllin.(letter)

J Infect 2000;40:102-319)

19) Ferguson JD, Banning AP

Ultrasound guided percutaneous thrombin injection for the treatment of iatrogenic pseudoaneurysms (letter)

Heart 2000; 83:582

20) Clarke NR, Banning AP

Mycotic aneurysm formation with dehiscence of a valved aortic conduit resulting in dynamic left ventricular outflow obstruction

Heart 2000; 84: 271

21) Westaby S, Banning AP, Jarvik R, Frazier OH, Pigott DW, Catarino PA, Saito S, Robson D, Freeland A, Myers T, Poole-Wilson PA.

First permanent implant of the Jarvik 2000 Heart

Lancet 2000; 356:900-3

22) Clarke NR, Roskell D, Banning AP

Surgical resection of an asymptomatic aortic valve papillary fibroelastoma in a young man.

Heart 2000;84: 578

23) Clarke NR, Banning AP

Obliteration of a coronary aneurysm with a covered coronary stent

Heart 2001; 86:198

24) Mackenzie IM, Banning AP, Dyar O.

Pharmacological exposure of an occult atrial septal defect.

Critical Care Medicine 2001; 29:1832-4

25) Taggart DP, Banning AP, Channon K

Coronary artery bypass surgery vs stenting for multivessel disease (letter)

N Engl J Med 2001 :345;1641-2

26) Jin XY, Westaby S, Robson D, Catarino PA, Saito S. Banning AP

Unique ECG finding in a patient with an axial blood flow pump

Circulation 2001 :104; 970-1

27) Clarke, NRA Banning AP, Gwilt DJ, Scott AR,

Pericardial Disease Associated With Grave’s Thyrotoxicosis

QJM 2002 ; 95:188-9

28) Niccoli G, ,Orr WP, Banning AP,

Extensive right coronary artery dissection following cutting balloon treatment of in-stent restenosis

J Invasive Cardiol ; 2002; 14: 209-11

29) Niccoli G, ,Heck PM, Banning AP,

Cyanosis, cortriatriatum and primum atrial septal defect in an adult

Heart ; 2002; 88:136

30) Clarke, NRA, Mohaiadin R, Westaby S, Banning AP,

Multifocal cardiac leimoysarcoma:diagnosis and surveillance by transoesophageal echocardiography and contrast enhanced cardiovascular magnetic resonance

Post Grad Med J 2002 ;78:492-3

31) Niccoli G, Martin J, Banning AP.

Attempted retrograde reopening of an occluded left main stent.

Ital Heart J. 2002 ; 3 :483-5.

32) Timperley J, Clarke NRA, Banning AP

New antiplatelet agents and prosthetic heart valves.
QJM. 2002;95 :706-7

33) Saito S, Banning AP, Giele, H, Westaby S.

Mycotic false aneurysm of the ascending aorta

Ann Thorac Surg. 2003 ;75:1331.

34) Timperley J, Banning AP

Intramural aortic haematoma (letter)

Circulation 2003 107:e63

35) Mitchell ARJ Timperley J, Banning AP

Synergistic anticoagulation and transoesophageal echocardiographic surveillance for persistent left atrial appendage thrombus

Heart 2003 89;1022

36) Nicolson D, Porto I, Westaby S, Boardman P, Banning AP

Spontaneous echocardiographic contrast in the ascending aorta mimicking the apperance of aortic dissection in a patient with a left ventricular assist device.
Echocardiography. 2004 ;21:193-5.

37) Choudhury RP, Porto I, Banning AP

Debris trapped by a distal protection device may mimic ‘no-reflow’ during percutaneous coronary intervention

Circulation 2004;109 803-804

38) Porto I, Choudhury RP, Banning AP

Embolisation during treatment of a partially thrombosed saphenous vein graft

Eur Heart J 2004 ;25: 1

  • Porto I, Banning AP

Intravascular ultrasound in the diagnosis and treatment of spontaneous coronary artery dissection with drug eluting stents

J Invas Cardiology 2004;18:78-80

40) Mitchell A, Eichofer J, Banning AP

Emergency endovascular aortic stenting for the treatment of a ruptured atherosclerotic ulcer

Heart 2004;90: 793

41) Porto I, Choudhury RP, Banning AP

Oversized semicompliant balloon to dilate “undilateable” stenosis

Heart 2004;90:485

42) Shirodaria CC, Mitchell ARJ, Banning AP

Emergency balloon mitral valvotomy for severe mitral stenosis during pregancy

Heart 2004 ;90:934

43) Porto I, Banning AP

Unstable angina in a patient with a single coronary artery

Heart 2004:90; 858

44) Porto I, Shirodaria CC, Banning AP

Intravascular ultrasound appearances of the “crush” technique for treatment of bifurcation coronary stenosis

Heart 2004 :90:1216.

45) Porto I, MacDonald S, Banning AP

Intravascular ultrasound is a significant tool for the treatment of coronary aneurysms

Cardiovasc Intervent Radiol. 2004; 27: 666-8.

44) Porto I, Mitchell AR, Ashar V, Banning AP

Intravascular ultrasound to guide the management of intracoronary thrombus

Cardiovasc Ultrasound. 2004 ; 2:18

46) Myerson SG, Mitchell AR, Ormerod OJ, Banning AP.

What is the role of balloon dilatation for severe aortic stenosis during pregnancy?
J Heart Valve Dis. 2005;14:147-50.

47) Porto I, Mitchell AR, Selvanayagam JB, Neubauer S, Banning AP

Percutaneous treatment of simultaneous aortic dissection and pericardial tamponade during coronary intervention

Int J Cardiol. 2005 ;105:104-7.

48) Porto I, Banning AP

Use of a sirolimus-eluting stent to treat failure of a non polymer release paclitaxel-eluting stent implanted for in-stent restenosis

J Invasive Cardiol. 2005; 17:270-3

49) Porto I, Van Gaal W, Banning AP

Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. (letter)

Eur Ht J 2005 20:2006

50) Van Gaal W, Porto I, Banning AP

Treatment of spontaneous coronary dissection with drug-eluting stents–late clinical, angiographic and IVUS follow up.
J Invasive Cardiol. 2006;18:E93-4

51) Van Gaal W, Porto I, Banning AP

Guide wire fracture with retained filament in the LAD and aorta.
Int J Cardiol. 2006 Sep 20;112:e9-11

52) Porto I, Van Gaal W, Banning AP

Crush and reverse crush technique to treat severe left main stenosis

Heart 2006; 92:1021

53) Porto I, Macdonald ST, Selvanayagam JB, Banning AP.

Intravascular Ultrasound to Guide Stenting of an Anomalous Right Coronary Artery Coursing between the Aorta and Pulmonary Artery

J Invasive Cardiol. 2005 (11) :E33-6.

54) Van Gaal W, West N, Banning AP

Myocardial infarction caused by distal embolisation of a ruptured left main plaque

Heart 2006; 92:1101

55) Jennings B, Van Gaal W. Banning AP

Extrinsic Compression of an Anomolous Right Coronary Artery Causing Cardiac Arrest

Heart 2007 :93 :52

56) Arnold R, Van Gaal W, Banning AP

Thrombotic occlusion of a Drug Eluting Stent – Is IVUS Mandatory?

J Invasive Cardiol. 2006 ;18:E238-40

57) Cheng AS, Banning AP, Mitchell AR, Neubauer S Selvanayagam JB

Cardiac changes in systemic amyloidosis: Visualisation by magnetic resonance imaging.

Int J Cardiol 2006. 26;113:E21-3.

58) Ryding A, van Gaal WJ, Banning AP

Coronary stent fracture in an anomalous coronary artery

EuroIntervention 2007 ; 3 no 1

59) Shirodaria C,Van Gaal WJ, Banning AP

A Bleeding Kiss: Intramural haematoma secondary to balloon angioplasty.
Cardiovasc Ultrasound. 2007 ;5:21

60) Van Gaal W,. Jennings B, Banning AP

Late adverse ventricular remodelling as a consequence of acute left main coronary occlusion

Heart 2007;93 1019

61) Westaby S, Channon K, Banning AP

To stent or not to stent?: A sterile debate.(letter)
Brit Med J. 2007 ;335 (7611):111

62) Schrale R, Van Gaal WJ, Banning AP

Late stent thrombosis, 28 months after implantation of a left main coronary drug eluting stent

Heart, Lung and Circ 2007;16:378–379

63) Porto I, Testa L Banning AP

Plaque burden, Intravascular ultrasound and distal embolisation phenomenon (letter)

J Am Coll Cardiol 2008; 51 (13) 1323-4

64) Arnold JR, Banning AP

Stents versus bypass grafting for left main coronary artery disease. (letter)

N Engl J Med. 2008 ;359:424-5

65) Testa L Bhindi R, Banning AP

The hurdles of translating a single-center observation into practice.

Arch Intern Med. 2008 ;168:1719-20

66) Asrress K; Banning AP, Mitchell AR

‘Spontaneous coronary artery dissection’

BMJ Case Reports 2010; doi:10.1136/bcr.06.2008.0221

65) Testa L Bhindi R, Banning AP

Digitalis: a dangerous drug in atrial fibrillation? (letter)

Heart. 2008 ;94:1654.

66) Bhindi R Testa L, Ormerod OJ Banning AP

Rapidly evolving giant coronary anerysm

J Am Coll Cardiol. 2009 ;53:372.

67) Testa L, Banning AP

Primum non nocere: case report of a patient with aortic valve replacement and subsequent occlusion of an anomalous Circumflex artery

Eurointervention 2009;5 no 1

67) Testa L, Latini RA, Agostoni P, Banning AP, Bedogni F

Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery (letter)

Am J Cardiol 2009 103 (11):1622-3

68) Westaby S, Banning A, Neil D, Poole-Wilson P, Frazier OH

Optimism derived from 7.5 years of continuous flow circulatory support

J Thorac Cardiovasc Surg. 2010 ; 139 :e 45-7.

69) Periprocedural Myocardial Injury: Not a Benign Entity (letter)

Lim CCS. Van Gaal WJ , Banning AP
J. Am. Coll. Cardiol. 2010 55: 503

70) Does atherosclerosis protect from Takotsubo (letter)

Cucculi F, Lim C, BanningAP

Cardiology 2010;116:58

71) Lim C, Banning AP, Channon K

Optical coherance tommography in the diagnosis of and treatment of Spontaneous Coronary Artery Dissection

J Invasive Cardiology 2010 22(11) 559-60

72) Resistant pericardial tamponade

Cucculi F, Newton J , BanningAP , Prendergast B

Circulation 2011 ; 123: 566-7

73) How should I treat a long and huge coronary pseudo aneurysm after spontaneous coronary dissection- How could I treat

Furuichi F, Montofano M, Godinio C, Murio M, Sangiorgi GM, Columbo A, Sabate M, Banning AP

Eurointervention 2011:6; 1131-6

74) Large perfusion defect on scintigraphy explained by severe microcirculatory dysfunction

Cucculi F, De Caterino A , BanningAP ,

J Invasive Cardiol. 2011 Oct;23(10):E247-8

75) Universal Definition Methodology and Conclusions Are a Concern (letter in reply)

Banning AP

  1. Am. Coll. Cardiol. 2011;58;314-315

76) Diagnostic Criteria for Percutaneous Coronary Intervention-Related Myocardial Infarction: Time for Revision? (letter in reply)

Banning AP
J Am Coll Cardiol 2011 58: 312-313.

  • Axial deformation during coronary stenting: an extreme case!

De Caterino A , Cucculi F, Banning AP ,

J Invasive Cardiol 2012 E122-3

78) Aberrant right subclavian artery haematoma following radial catheterization

Kassimis G, Patel N, Sabharwal N, Banning AP

JACC Cardiovasc Intv 2013 :6(6) 636-7

79) Intravascular ultrasound-guided revascularization of a chronically occluded left main coronary artery

De Caterino A , Cucculi F, Banning AP ,

Indian Heart J. 2013; 65(2):194-7.

80) Unprotected Single Coronary Artery Main-Stem Angioplasty

Patel N, Sabharwal N, Banning AP

Heart. 2013 Nov;99(21):1626. doi: 10.1136/heartjnl-2013-304245

81) Novel Indication for Bio-absorbable Scaffolds in Metal Allergy

Patel N, Mechery A, Kassimis G Banning AP, Kharbanda R

Eurointervention 2013

82) Two rings too tight : sequential emergency PCI for hemodynamic and arrhythmic complications of mitral and tricuspid valve repair

Patel N, Banning AP

Catheterisation and Cardiovascular intervention 2014 Jan 1;83(1):E73-6.

83) Sequential spontaneous coronary dissection/mural haematoma within all three coronary arteries over a nine year period

Kassimis G, Patel N, Banning AP

Hellenic J Cardiol. 2014 Jan-Feb;55(1):58-60

84) IVUS-guided High Pressure Non-Compliant Balloon dilation to treat in-DES-Restenosis

Kassimis G, Patel N, Banning AP

J Invasive Cardiol. 2014 Jul;26(7):348

85) Diagnosis of an abnormality in the Left main coronary

De Maria GL. Ruparelia N, Kharbanda R Banning AP

Heart. 2014 Jun;100(11):891, 893

86) Management and optical coherence tomography imaging of an acute coronary artery injury induced by radiofrequency catheter ablation

Leo M, De Maria GL, Betts T, Banning AP

Int J Cardiol. 2014 Jun 15;174(2):e44-6.

87) Eculizumab treatment for paroxysmal nocturnal hemoglobinuria in a patient with recurrent simultaneous multivessel coronary stent thrombosis

De Maria GL. Sarwan R, Banning AP

Oxford case reports 2015 doi:10.1093/omcr/omu063

88) Iatrogenic constrictive remodeling of left main stem after left coronary cusp atrial tachycardia ablation

De Maria GL De Maria GL Pedersen M, Leo M, , Bashir Y, Banning AP

Int J Cardiol. 2015 Feb 27;184:507-509. doi: 10.1016/j.ijcard.2015.02.099

89) Left internal mammary artery graft stenosis and post-angioplasty restenosis: follow-up through multi-slice cardiac computed tomography angiography
Kassimis G, Patel N,. Sabarwal N, Banning AP

Minerva Cardiologica

90) Reply: Is Coronary Wedge Pressure a Technique to Identify High-Risk Patients Who May Benefit From Alternative Treatment in Acute Myocardial Infarction?: Is This The Next Step?

Patel N, Banning AP, Kharbanda R

JACC Cardiovasc Interv. 2016 Jan 11;9(1):105. doi: 10.1016/j.jcin.2015.10.016

91) Stent Implantation Is a Durable Therapy for an Aberrant Right Coronary Artery Causing Cardiac Arrest.

Wolfrum M, Sabarwal N, Banning AP

J Interventional Cardiol 2016

1) Banning AP.

Bacterial Meningitis in Fiji.

Protection Matters 1988; 18:17-23

2) Banning AP, Avery PA, McGurk L, Fraser AG, Buchalter MB.

The use of audit to assess and modify pacing practice in a Regional Cardiac Centre.

Br J Cardiol 1994; 1:138-141

3) Mumford AD, Banning AP, Elborn JS.

Hepatocellular carcinoma: an unusual cause of tricuspid regurgitation

Hospital Update 1996 June 260-3

4) Banning AP

An Atlas of Infective Endocarditis. by C Ward (Book review)

J R Coll Physicians London 1996; 30: 266

5) Banning AP.

Don’t miss aortic stenosis: Very old may gain from surgery.

Health and Ageing 1997; May : 26-7

6) Banning AP.

Emergency cardiology

Medicine 1998; 26:2: 194-8

7) Banning AP.

Don’t miss valvular heart disease: Who needs an echocardiogram?

Health and Ageing 1998; May: 30-34

8) Banning AP.

Management of TIA’s: advantages of a systemic approach?

Health and Ageing 1999; March ;37-39.

9) Banning AP.

Managing valvular heart disease in general practice

The Practitioner 1999 ;243:740-5

10) Pantaleo P, Banning AP

Incomplete rupture of an ascending aortic aneurysm detected by transoesphageal echocardiography.

International J of Cardiov Dis 2000;17:39-41

11) Banning AP.

Has PTCA come of age?

Health and Ageing 2000 February ;33-35

12) Clarke NC, Banning AP.

Murmurs in adults: when should you take action?

The Practitioner 2000 ;244:554-6

13) Alp N, Banning AP.

Advances in therapy change views

Health and Ageing 2000 October; 17-20

14) Banning AP, Nicolson D

Put your stents in early

Health and Ageing 2002 November;18-22

15) Blackman D, Banning AP,

Day case coronary intervention

Interventional Cardiology 2003 ;9 (4) :2-5

16) Porto I, Banning AP

Are clot busters best?

Health and Ageing 2003 March; 19-20

17) Blackman D, Choudhury R, Banning AP,

Day case coronary intervention

Interventional Cardiology Monitor 2003 ;10 (3) :61-8

18) Shirodaria C, Banning AP

Whats new in ischaemic Heart disease and MI

Medicine 2004;

19) Blackman D, Banning AP,

Bivalarudin:in percutaneous coronary intervention

Acute and interventional cardiology 2004; 11 (3) : AIC 85-8

20) Shirodaria C, Banning AP

Whats new in Heart disease

Medicine 2005; 33:8

21) Banning AP,

Are drug eluting stents living up to the hype?

Acute and interventional cardiology 2005; 12 AIC: 42-44

22) Banning AP Lim CCS

Whats new in …. Cardiology

Medicine 2009; 37:7 385-8

23) Banning AP

Coronary stents – back to the future

Coronary heart 2010; 22: 8

24) Kassimis G Banning AP

Highlights from the latest articles in anti-thrombotic and myocardial revascularization strategies in coronary artery disease

Interventional Cardiology 2013;5:253-7

Adrian Banning Cardiologist Oxford

Heart and Circulatory System Hardcover – 2000
by BANNING (Dr Adrian P.)

Adrian Banning Cardiologist Oxford

The Year in Interventional Cardiology 2002 Hardcover – 20 Jan 2003
by H.D. White (Author), Pim J. de Feyter (Author), Bernhard Meier (Author), & 3 more

Adrian Banning Cardiologist Oxford

The Year in Interventional Cardiology 2003 Hardcover – 7 Nov 2003
by A.P. Banning (Editor), Pim J. de Feyter (Editor)

Adrian Banning Cardiologist Oxford

The Year in Interventional Cardiology: v. 3 Hardcover – 8 Mar 2005
by A.P. Banning (Editor), C. Di Mario (Editor)

Adrian Banning Cardiologist Oxford

Cardiac Catheterization and Coronary Intervention (Oxford Specialist Handbooks in Cardiology) Flexibound – 27 Mar 2008
by Andrew R. J. Mitchell (Author), Nick E.J. West (Author), Paul Leeson (Author), Adrian P. Banning (Author)

1) Banning AP, Hall RJC.

Structural and mechanical causes of cardiovascular syncope.

In: Kenny RA ed.

Syncope in the older patient.

Chapman and Hall: London 1996 pp. 201-219.

2) Prendergast BD, Banning AP, Hall RJC

Valvular heart disease: recommendations for investigation and management. Royal College of Physicians: London, 1996.

3) Banning AP, Hall RJC.

Aortic valve disease: management and indications for surgery

In: Westaby SA and Piwnica A ed.

Surgery for acquired aortic valve disease.

Isis Medical Media: Oxford 1997 pp 43-61

4) Banning AP, Gribbin B.

Valvular heart disease-timing for surgery

In: Yusuf S, Cairns J, Camm AJ, Fallen E, Gersh B eds.

Evidence based Cardiology

BMJ Publishing: London 1998, pp 1092-6

5) Banning AP

Percutaneous intervention in ischaemic heart disease
In Pillai R ed

Surgery for ischaemic heart disease

Oxford University Press: Oxford 1999 pp 25-41

6) Banning AP


Oxford Textbook of Medicine 4th Edition

Oxford University Press : Oxford 2003 pp

7) Banning AP, Gribbin B

Aortic dissection

Oxford Textbook of Medicine 4th Edition

Oxford University Press : Oxford 2003 pp

8) Banning AP, Gribbin B.

Valvular heart disease-timing for surgery

In: Yusuf S, Cairns J, Camm AJ, Fallen E, Gersh B eds.

Evidence based Cardiology

BMJ Publishing: London 2002, pp 934-9

9) Banning AP, Mitchell AR

Aortic dissection

In Myerson S, Choudhury R, Mitchell ARJ

Emergencies in Cardiology

Oxford University Press: Oxford 2005 pp169-181

10) Mitchell AR, Banning AP


Oxford Textbook of Medicine 5th Edition

Oxford University Press : Oxford 2010 pp

11) Mitchell AR, Banning AP

Aortic dissection

Oxford Textbook of Medicine 5th Edition

Oxford University Press : Oxford 2010 pp

12) Van Gaal WJ, Banning AP

Distal Protection

In Redwood S, Curzen N, Thomas M

Oxford Textbook of Interventional Cardiology

Oxford University Press : Oxford 2010 pp

13) Van Gaal WJ, Banning AP

Thrombectomy and distal protection

In Di Mario C, Dangas G, Barlis P

Interventional cardiology principles and practice

Wiley Blackwell: 2010 pp

14) Fahrni G, DeMaria GL, Banning AP

The use of IVUS to outline the mechanism of restenosis in a previously stented artery

In Escaned J, Serruys PW

Coronary stenosis, imaging structure and physiology
Europa Digital and Publishing 2015

15) De Maria GL, Banning AP

Thrombus containing lesions

In Di Mario C, Dangas G, Barlis P

Interventional cardiology principles and practice 2nd edition

Wiley Blackwell: 2016 pp

1) Daily Mail

Who’s the best surgeon for unblocking your arteries? Which ‘plumber’ would the experts choose to perform the risky op?

Angela Brooks; originally published 23 November 2010

2) The Voice

Health Matters; An Expert Opinion

Originally published 16-22 February 2012; p25

1) Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction

Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R;

HORIZONS-AMI Trial Investigators

N Engl J Med. 2009 May 7;360(19):1946-59

Banning AP listed by PUBMED as collaborator n= 171

2) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW;

SYNTAX Investigators

N Engl J Med. 2009 Mar 5;360(10):961-72.

Banning AP listed by PUBMED as collaborator n= 191

3) Bivalirudin during primary PCI in acute myocardial infarction

Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R;

HORIZONS-AMI Trial Investigators

N Engl J Med. 2008 22;358 :2218-30

Banning AP listed by PUBMED as collaborator n= 52

4) Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.

Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Wong SC, Nikolsky E, Gambone L, Vandertie L, Parise H, Dangas GD, Stone GW;.

HORIZONS-AMI Trial Investigators

Lancet. 2009 Oct 3;374. 1149-59

Banning AP listed by PUBMED as collaborator n= 171

5) Cost-effectiveness analysis of general anaesthesia versus local anaesthesia for carotid surgery (GALA Trial).

Gomes M, Soares MO, Dumville JC, Lewis SC, Torgerson DJ, Bodenham AR, Gough MJ, Warlow CP;

GALA Collaborative Group.

Br J Surg. 2010 ;97: 1218-25.

Banning AP listed by PUBMED as collaborator n= 7

6) A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of up to Two De Novo Coronary Artery Lesions) trial.

PLATINUM trial investigators

J Am Coll Cardiol. 2011 ;57 :1700-8.

Banning AP listed by PUBMED as collaborator n=216

1) July 1999 – 2006

Assistant Editor to the journal Heart (BMJ publications). Editor Prof Roger Hall

This involved handling up to 5 new manuscripts/ week – seeking peer review and liaising with the other members of the editorial team. During this time Hearts impact factor rose from 2 to 3.3

2) Hall RJC, Banning AP eds

Cardiovascular disorders (1-5)

Medicine 1997;

25.10 Symptoms, Clinical examination and Investigation

25.11 Ischaemic heart disease and Pulmonary embolism

25.12 Echocardiography and Valvular heart disease

26.1 Arrythmia and Heart failure

26.2 Paediatric and Emergency cardiology

3) Banning AP , Prendergast B eds

Cardiovascular disorders (1-5)

Medicine 2002;

30;3 Symptoms, Clinical examination and Investigation

30;4 Ischaemic heart disease and Pulmonary embolism

30;5 Arrythmia and Heart failure

30;6 Paediatric and Emergency cardiology

4) Banning AP , Prendergast B eds

Cardiovascular disorders (1-5)

Medicine 2006;

Symptoms, Clinical examination and Investigation

Ischaemic heart disease and Pulmonary embolism

Arrythmia and Heart failure

Paediatric and Emergency cardiology

Syntax score and Syntax lemans Substudy – recent updates for complex PCI

A review of the trial and how to apply the Syntax score to patients with severe coronary disease

Theres triple vessel disease and triple vessel disease: risk assessment

Applying recent trial data to the management of patients with severe coronary disease

Emerging stent technologies :adding innovations and new technologies to clinical practice

Discussion about how technology will evolve over the next 5yrs

Thrombolysis and infarct angioplasty understanding the recommendations of NIAP

A commentary and debate on the role of PPCI in the management of AMI.

PCI in patients with diabetes: show me data

A review of the literature comparing PCI and CABG in diabetics